CD4 and ovarian carcinoma: We found that aAPCs efficiently expand IL-2 cultured TILs from solid tumor specimens of ovarian cancer similar to the REM, resulting in a favorable CD4/8 T cell ratio, and low FOXP3+ CD4 T cell composition.